ATR and Miyoshi myopathy: The ability of ATR inhibitors to disrupt STAT3 function, critically important in MM cell survival, along with existing evidence that such cells are highly vulnerable to ATR inhibitor-induced replicative stress [7], makes development of these agents for a disease such as MM particularly attractive.